iopromide has been researched along with Extravascular Hemolysis in 2 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerk, U | 1 |
| Krüger, A | 1 |
| Franke, RP | 1 |
| Jung, F | 1 |
| Krause, W | 1 |
| Press, WR | 1 |
| Frenzel, T | 1 |
2 other studies available for iopromide and Extravascular Hemolysis
| Article | Year |
|---|---|
Effect of radiographic contrast media (Iodixanol, Iopromide) on hemolysis.
Topics: Aged; Contrast Media; Coronary Angiography; Erythrocyte Membrane; Erythrocytes; Female; Glomerular F | 2014 |
Preclinical testing of iopromide. 1st communication: pharmacological evaluation.
Topics: Animals; Bleeding Time; Complement Activation; Contrast Media; Dogs; Erythrocytes; Hemolysis; Histam | 1994 |